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Abstract 
 
Background: Spleen-deficiency syndrome (SDS) in Traditional Chinese Medicine (TCM) played pivotal roles on the 
development of hepatocellular carcinoma (HCC). This study was performed to establish and evaluate HCC model in 
mice with SDS in TCM.  
Material and Methods: A total of 90 C57BL/6 mice were randomized in six groups (n=15 for each group): A, Control 
group; B, SDS group; C, orthotopic HCC (OHCC) group; D, OHCC based on SDS (SDS-OHCC) group; E, Drug-
induced HCC (DHCC) group; F, DHCC based on SDS (SDS-DHCC) group. The SDS model were established by 
subcutaneous injection of reserpine, followed by the OHCC or DHCC model establishment. The SDS scores, tumor 
formation rate and survival time were recorded and calculated, as well as the histochemical stain was performed.  
Results: The SDS scores of mice in Group B, D, F were 17.57±4.86 (P<0.05 vs. Group A), 18.13±4.53 (P<0.05 vs. 
Group A and C) and 23.32±4.94 (P<0.05 vs. Group A and E) respectively. The tumor formation rate of mice in Group 
C, D, E and F were 73.33%, 100%, 60% and 80% respectively. The survival time of mice in Group C, D, E and F were 
26.42±5.27, 17.33±4.76 (P<0.05 vs. Group C), 35.77±6.12 and 22.61±5.05 (P<0.05 vs. Group E) respectively.  
Conclusion: The SDS-oriented HCC mice models were simple and easily-operated models for further studies on SDS 
oriented tumor. Meanwhile, SDS was a pivotal factor for low outcome of hepatic tumor. 
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Abbreviations: HCC, Hepatocellular carcinoma; OHCC, Orthotopic hepatocellular carcinoma; DHCC, Drug-induced 
hepatocellular carcinoma; SDS, Spleen-deficiency syndrome; TCM, Traditional Chinese Medicine; SPF, Specific 
pathogen-free; DEN, Diethylnitrosamine; CCl4, Carbon tetrachloride; HE, Hematoxylin-eosin; IACUC, Institutional 
Animal Care and Use Committee. 
 
 
Introduction 
 
Hepatic tumor is generally known as a malignant tumor the world over. It is the second leading cause of 
cancer death globally (Petrick et al., 2016). Literature documentation showed that hepatic tumor ranked sixth among 
morbidity scale of all tumors (Mohammadian et al., 2016). In addition, more than 80% new hepatic tumor cases were 
reported in Asia and Africa, of which half were Chinese patients. According to previous studies, hepatic tumor 
mortality increased to the second place among all cancer cases in China (Fang et al., 2015). It was well documented 
that multiple factors, pathways and steps, including the external environment such as virus, parasite and bacterial, 
internal environment, contributed to the primary hepatic carcinoma (Clark et al., 2015). Generally, genetic factors could 
only account for 5% of the tumor pathogenesis, whereas the coefficient of external and internal environment showed its 
influence on most tumors (Bhattacharjee et al., 2013). The internal environment, considered appropriate for the 
development of carcinoma, are believed to be one of the most pivotal factors in the formation of tumors (Xu et al., 
2013). How genetic factors affected the development of tumors remains unclear, thus it is better to change the external 
living environment or adjust the internal environment during the prevention and treatment procedure of hepatic tumors. 
In the theory of Traditional Chinese Medicine (TCM), pathogenesis of hepatic tumor is total in external and 
internal factors, the former includes Liuyin Disease (six climatic exopathogens) and improper diet while the latter of 
which includes the deficiency of Qi and Blood or Yin and Yang, or accumulation of pathogenic toxin, leading to hepatic 
mass (Liu and Li, 2012). In the theory of TCM, spleen-deficiency syndrome (SDS) is both organic disorders and 
functional changes which are widely associated with different systems, organs and tissues. It was proven that changes 
of most indices or indicators could be attributed to SDS. On the other hand, any of those changes of indices or 
indicators may not be found in SDS. To sum up, individuals with SDS may suffer from digestive problems such as 
loose stools, abdominal distension following meals, sallow complexion, and loss of appetite, weight loss, and general 
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weakness and/or lower disease resistance. Several TCM researchers demonstrated that the symptoms of the hepatic 
tumor reflected on the liver while the root of which attributed to spleen, consequently the spleen-deficiency was the 
basic pathogenesis of hepatic tumor (Li et al., 2014; Sun et al., 2008). Since the treatment for hepatic tumor is limited 
and unsatisfied, it is necessary for researchers to focus on alternative and complementary therapies such as TCM.  
Since SDS played pivotal roles on different kinds of diseases and thereafter became a basis for their 
pathogenesis, the SDS models were frequently established so as to further explore the corresponding mechanism or 
treatment. The SDS models had been well established according to the requirement of different studies. In details, the 
spleen Yang deficiency model could be established by single factor methods such as injecting hydrocortisone and 
gavaging Sennae Folium or by compound factors way such as gavaging adenine, improper diet and exhaustion (Pan et 
al., 2014) whereas the spleen Qi deficiency model could be conducted by oral administration of Radix Rhei extract as 
well as the loaded swimming and starvation for 24 hours (Zheng et al., 2014; Tian et al., 2015; Chen et al., 2014a; Liu 
and Shi, 2015). As for hepatic tumor model, the most common used approaches for orthotopic transplantation HCC 
model were intravenous, intrasplenic, intrahepatic inoculation of tumor cells and intrahepatic tissue implantation, of 
which the orthotopic intrahepatic tissue implantation was regarded as the favorable approach (Rao et al., 2016). Even 
though the spleen deficiency has been well accepted to be an important issue for the development and formation of 
hepatic tumor, less information concerning the animal model of hepatic tumor based on spleen deficiency was found, 
thus it is necessary to introduce a new and modified animal model for further investigation in this field. 
In this study, an orthotopic liver transplantation model and drug-induced model in mice with SDS was 
performed according to the theory of TCM, the general state was observed and the SDS model was evaluated by SDS 
Scale, additionally the tumor formation rate and survival rate were analyzed, as well as the morphological analysis was 
conducted by histochemical stain, by which the alternative strategies for SDS-oriented hepatic tumor could be further 
explored prospectively.  
 
Materials and Methods 
Animals and cell line 
 
The whole experimental procedure was performed in the Animal Experimental Center of Sun Yat-sen 
University (Guangzhou, China). In total 90 specific pathogen-free (SPF) C57BL/6 mice (male; age, 6 weeks; weight, 
20±2 g; series No.: 44008500006598) and 1 SPF BALB/c nude mice (male; age, 4 weeks; series No.: 44008500003892) 
were purchased from the Animal Experimental Center of Sun Yat-sen University (Certification No.: SYXK 
(Guangdong) 2012-0081; Guangzhou, China). The hepal-6 mouse cell line was acquired from the Cell Bank of the 
Laboratory Center of Sun Yat‑Sen University. All the procedure was monitored strictly by the Institutional Animal 
Care and Use Committee (IACUC), Sun Yat-sen University according to the “3R” principles with humanism care to 
the experimental animals (Ethical Approval No.: IACUC-2013-1002). 
 
Study design 
 
A total of 90 mice were randomized into six groups (n=15 per group) in the SPF laboratory as follows: A, 
Control group, animals received normal food and water; B, Spleen-deficiency syndrome (SDS) group, animal received 
SDS model establishment; C, Orthotopic Hepatocellular Carcinoma (OHCC) group, animals received OHCC model 
establishment; D, SDS-OHCC group, animals received OHCC model establishment followed by the SDS model being 
accomplished successfully; E, Drug-induced Hepatocellular Carcinoma (DHCC) group, animals received DHCC model 
establishment; F, SDS-DHCC group, animals received DHCC model establishment followed by the SDS model being 
accomplished successfully. Animals in Group B, C, D, E and F started to receive the corresponding model 
establishment following 7 days of free feeding for food and water.  
 
Establishment of SDS model 
 
The mice were housed in a dry SPF environment between 24
o
C to 26
o
C temperature range at 12-h light/dark 
cycle with free feeding. The mice in the SDS Group and SDS-OHCC Group received the injection of reserpine (Jinyao 
Amino Acids Co., Ltd., Tianjin, China) with a dose of 0.1 mg/kg subcutaneously (Zhao et al., 2011; Gao et al., 2009; 
Ren et al., 2000) while the mice in Control Group and OHCC Group received 0.9% Sodium Chloride Solution (Kelun 
Pharmacy Co., Ltd., Sichuan, China) at a dosage of 2 ml subcutaneously for 14 days continuously. The body odor, 
mental state, respiration, hair, feces and food-intake were observed and afterwards the SDS scores were recorded based 
on the SDS Scale listed in Table 1 in order to evaluate the SDS level. According to the previous study (Sun et al., 2016; 
Shen and Wang, 1987; Zhang et al., 2014; Chen et al., 2014b), the SDS Score below 7 was defined as “Non-SDS”, 7-
14 as “Mild-SDS”, 15-21 as “Typical-SDS” and above 22 as “Severe-SDS”. 
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Establishment of HCC models 
 
For the OHCC mice model establishment, at the first stage, 0.2 ml hepal-6 mouse HCC cell lines (1×10
7
/ml) 
was transplanted subcutaneously through the injection in the neck of the nude BALB/c mouse. The tumor was 
harvested after reaching a diameter of 10 mm at approximately 10 days (Rao et al., 2016). The mouse was anesthetized 
by an intraperitoneal injection of 10% chloral hydrate (3.5 ml/kg; Sigma-Aldrich Shanghai Trading Co., Ltd., Shanghai, 
China), afterwards the tumor tissue was carefully transferred to the sterilized Saline solution with the necrotic tissue 
being removed. Then the tumor was cut into 1-mm
3
 pieces and transferred to 4
o
C environment prior to being 
transplanted. 7 days after the establishment of SDS model, the mice in OHCC Group and SDS-OHCC Group were 
anesthetized through intraperitoneal injection of 10 % chloral hydrate (3.5 ml/kg) in associated with the ether inhalation 
anesthesia, thereafter while 75% alcohol sterilized, the livers were exposed after a vertical incision under the xiphoid 
was cut. Subsequently, while the alcohol gauze was hold the liver lobe up, the prepared tumor tissues were implanted 
into subcapsular of left lobe of liver via the coarse needle (Becton Dickinson Medical Devices Shanghai Co., Ltd., 
Shanghai, China) with a 20
o
 intersection angle between the needle and liver. Finally, the hemostasis and penicillin 
sterilization for abdominal cavities were performed followed by the closure of the abdominal cavities layer by layer 
using 5# suture (Becton Dickinson Medical Devices Shanghai Co., Ltd., Shanghai, China). The states of animals were 
strictly monitored till 35 days after model established, the tissues and organs would be harvested for further 
explorations. 
For the DHCC mice model establishment, the whole procedure could be divided into four sections. Firstly, the 
mice received a single abdominal injection of Diethylnitrosamine (DEN) (Sigma-Aldrich Shanghai Trading Co., Ltd., 
Shanghai, China) with an initial dose of 0.095 mg/g at the first day; afterwards from the 4
th
 day on, they received the 
intra-gastric administration of the mix compound of Carbon tetrachloride (CCl4) (Sigma-Aldrich Shanghai Trading Co., 
Ltd., Shanghai, China) and Olive oil (Sigma-Aldrich Shanghai Trading Co., Ltd., Shanghai, China) (CCl4 : Olive oil = 
1:4) with a dose of 0.005 ml/g for twice a week; thereafter from the 3
rd
 week on, they received another single 
abdominal injection of DEN with a reduced dose of 0.05 mg/g as well as the Spirit (Alcohol content, 55%; Red Star 
Co., Ltd., Beijing, China) was began to administrated intragastrically with the initial dose of 0.05 ml/g; finally from the 
4
th
 week on, the mice received the increased dose of both CCl4 compound and  Spirit for 0.008 ml/g and 0.07 ml/g 
respectively. Unlike the OHCC model, it was at least 42 days that the DHCC model could be established successfully 
according to our preliminary experiment, therefore all the vital indexes were strictly monitored and recorded until the 
corresponding organs and tissues were harvested. 
 
Histochemical stain 
 
The hepatic tissue of mice in Control Group and SDS Group and the tumor tissues of mice in the rest Groups 
were the histochemical stain with the hematoxylin-eosin (HE) (Hematoxylin solution and Eosin Y; Sigma-Aldrich 
Shanghai Trading Co., Ltd., Shanghai, China). The tissues were conducted the paraffin embedding and section and 
afterward performed the HE staining according to the instruction. The stained sections were observed by the 
microscope. 
 
Statistical analysis 
 
The data were analyzed with SPSS software (Version 17.0; SPSS, Inc., Chicago, IL, USA). The analysis of variance 
was used for the normal distribution measurement data; the chi-square test was used for the continuous measurement 
data while the Kaplan-Meier survival analysis was used for the survival analysis. P<0.05 was considered to indicate a 
statistically significant difference.  
 
Result 
General state of animal models 
 
After injecting the hepal-6 mouse HCC cell lines subcutaneously to the back of the nude BALB/c mouse, the 
tumor tissue developed gradually. Approximately 10 days later, an obvious 10 mm-diameter tumors raised up from the 
skin, which indicated that the hepatocellular carcinoma tissue had been formatted successfully (Figure 1A). After 
receiving the establishment of the SDS models, the mice showed different level of spleen-deficiency syndrome such as 
fatigue, arched back with trembling, faint especially the brown and erected fur (Figure 1B). For the Control Group, the 
mice showed no specific situations and survived well for the whole experimental procedure. For the OHCC Group and 
SDS-OHCC Group, the mice showed typical cachexia symptoms while being implanted the tumor tissues, in brief, the 
mice got the abdominal distension mostly caused by the ascites, mental fatigue, anorexia, weight loss and some other 
tumor-related symptoms. The dissection for organ and tissue preparation verified the ascites had been formatted and the 
HCC tissue could easily be confirmed visibly (Figure 1C). Similarly, the mice in the DHCC Group and SDS-DHCC 
Group also showed the symptoms as above, however they were not as severe as the mice in OHCC Group and SDS-
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OHCC Group, besides, it took more time to format the tumor which was also with smaller visible volume compared to 
that of OHCC and SDS-OHCC Group (Figure 1D).  
 
 
The evaluation of SDS models 
 
The evaluation for SDS models was conducted in all mice including the Control Group, OHCC Group and 
DHCC Group so as to assess the SDS model and the relationship between spleen-deficiency and hepatocellular 
carcinoma. By observing towards SDS model establishment procedure, the mice in Control Group showed no spleen-
deficiency (4.28±2.72) while the mice in SDS Group had typical spleen-deficiency (17.57±4.86). For the tumor groups, 
the OHCC mice were similar as Control mice which had no spleen-deficiency (3.98±2.76) while SDS-OHCC mice 
were similar as SDS mice which also had a typical spleen-deficiency (18.13±4.53); the DHCC mice originally showed 
a mild spleen-deficiency (8.12±2.33) while SDS-DHCC showed a severe spleen-deficiency (23.32±4.94) (Figure 2).  
 
 
 
 
 
 
Figure 1: General state of animal models. (A) A visible 10 mm-diameter tumor raised up from the skin of the nude 
BALB/c mouse while being injected the hepal-6 mouse HCC cell lines subcutaneously to the back; (B) The mouse 
which received the SDS modeling showed typical spleen-deficiency syndrome such as fatigue, arched back with 
trembling, faint especially the brown and erected fur; (C, D) The dissection for tissue preparation showed the tumors 
had been formatted visibly in the OHCC and DHCC models respectively. HCC, Hepatocellular carcinoma; SDS, 
Spleen-deficiency syndrome; OHCC, Orthotopic hepatocellular carcinoma; DHCC, Drug-induced hepatocellular 
carcinoma. 
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Figure 2: The evaluation of SDS models by SDS scores. *P<0.05 vs. Control group; #P<0.05 vs. OHCC group; & 
P<0.05 vs. DHCC group. SDS, Spleen-deficiency syndrome; OHCC, Orthotopic hepatocellular carcinoma; DHCC, 
Drug-induced hepatocellular carcinoma. 
 
Tumor formation and survival analysis 
 
The tumor formation rate and survival time for HCC model mice were illustrated in Figure 3. For the mice 
which received OHCC model establishment, 73.33% of which developed the tumor successfully and the mean survival 
days was 26.42±5.27; while the OHCC mice were SDS-oriented, the tumor formation rate increased to 100% and they 
survived for the shortest days (17.33±4.76). For the DHCC model, only 9 of 15 mice formatted the tumor tissues 
(60.00%) and the survival time were the longest (35.77±6.12); in the event of these mice got the SDS in advance, the 
tumor formation rate raised to 80.00% and they survived shorter (22.61±5.05). 
 
Figure 3: Tumor formation rate and survival time of HCC model mice. (A) Tumor formation rate of the mice in 
HCC models. (B) Survival time of the mice in HCC models. *P<0.05 vs. OHCC group; #P<0.05 vs. DHCC group. 
HCC, Hepatocellular carcinoma; SDS, Spleen-deficiency syndrome; OHCC, Orthotopic hepatocellular carcinoma; 
DHCC, Drug-induced hepatocellular carcinoma. 
 
Histochemical stain 
 
The hematoxylin-eosin (HE) stain results showed that for mice in the Control Group, the constructions of 
hepatocytes were in normal situation with aligned nuclei, full-constructed hepatic lobes, radially-distributed hepatic 
cords and apparent hepatic sinusoids (Figure 4A), similarly, the mice in SDS Group had almost the same constructions 
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excepted for small part of irregularly distributed hepatocytes (Figure 4B). In contrast, for the mice which received HCC 
modeling, it showed the different level of dysfunctions and damaged hepatocytes. To be specific, the carcinoma cells 
were microscopically nest-like distributed and accumulated irregularly without the normal hepatocytes constructions 
(Figure 4C-F). 
 
Table 1: The evaluation standard of Spleen Deficiency Syndrome Score. 
 
 
 
 
Conclusion 
 
The SDS-oriented OHCC mice model was established successfully, which could be a simple and easily-operated model 
for the further researches on spleen-deficiency caused tumor in TCM. While the foundation of spleen-deficiency 
Index/Score 1 2 3 4 
Body odor Odor-free Mild odor Medium odor Severe odor 
Mental state Stable Irritable Fatigue Somnolence 
Chill & fever Normal Cowered Chill Arched back & trembling 
Respiration Normal Panting Tachypnea Faint 
Fur Gloss Matted Fluffy & erect Brown & erect 
Feces Formed Loose Wet & loose Mucous 
Appetite Normal Reduced to 50% Reduced to 25% Not at all 
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existing, the HCC was showed to be developed earlier and rapidly and spleen-deficiency factor in advance was proven 
to be harmful for surviving. 
 
Discussion 
 
In theory, TCM individuals who are deficiency in spleen and kidney or weak and imbalance in their bodies 
mostly suffer from abdominal masses disease. Moreover the masses or tumor tissues are developed in the liver as a 
result of the long-time spleen-deficiency, which lead to heat, stagnation of liquid, extravasation of blood in the liver. In 
addition, it is reported previously that several HCC patients have already suffered from spleengastric problems for a 
long time; it is the spleen-deficiency that potentially leads to the HCC (Ni et al., 2012). Likewise, in the views of 
modern researches, the functions of protection and the source of acquired constitution of the spleen properly reflect that 
the spleen plays a pivotal role on the body defense, which is in closely related to the immune system including the 
specific immunity and non-specific immunity such as humoral and cellular immunities (Chen et al., 2014b). In 
summary, since the spleen-deficiency is regarded as one of the most vital pathophysiological bases, it is necessary to 
establish the HCC model based on the SDS, by which the pathogenesis in TCM and the molecular basis of hepatic 
cancer could be well investigated. 
Several previous studies had been focused on the OHCC and DHCC animal models. It was reported that the 
transplanted hepatocellular carcinoma models are characterized by implanting the hepatic tumor tissues from the 
human or animals, hepatic tumor cell lines or even non-liver-oriented tumor tissues such as breast cancer or colorectal 
cancer into the bodies of experimental animals (Yan et al., 2013). It is well accepted that the transplanted HCC models 
can be mainly divided into OHCC model and subcutaneously transplanted HCC, however the OHCC not only 
maintains the original constructions of tumors, but also the microenvironment in the abdominal cavity and the most 
biological characteristics compared to the subcutaneously transplanted HCC (Zheng et al., 2000). It is reported by now 
that the rats are more often used for HCC, nevertheless the mice models are regarded as low-price, easily-housing and 
simply-operation, which can be utilized for drug screening and large-scale researching projects (Bai et al., 2011). The 
drug-induced HCC model are generally used for simulating the hepatic tumor which is accumulated by long-time 
administration of different kinds of medications (Caviglia and Schwabe, 2015), while alcoholic beverages being 
included, it could also simulate the alcoholic liver cancer additionally (Thompson et al., 2015). For the substances used 
for inducing the HCC in this study, the DEN is a highly toxic chemical characterized by high risks for carcinogenicity, 
teratogenicity and genetic mutation, which is often used for induced HCC in mice (Zhao et al., 2015); the CCl4 is also a 
common toxic chemical in the fields of chemical engineering and paint which can be a main component of rubber, 
detergent, pesticide and so on, except for the risks above, furthermore it has chronic toxicity on kidney and liver and 
could lead to hepatic steatosis, cirrhosis and enlargement of kidney (Cai et al., 2015); the spirit contains high content of 
alcohol, the 90% of which will be decomposed in liver, thereafter the ethyl alcohol and its metabolite acetaldehyde 
could directly damage the hepatocytes and probably lead to HCC (Testino et al., 2014). 
In this study, the OHCC mice model based on the SDS was established successfully with a 100% tumor 
formation rate, which indicated that as a most proximate HCC model to the development and formation of hepatic 
tumor in human beings, the OHCC mice model could be used for exploring the pathogenesis in TCM and new 
strategies for HCC. On the other hand, the results for DHCC and SDS-DHCC models showed that when mice suffered 
from spleen-deficiency, the tumor formation rate increased from 60% to 80%, which implied that SDS could be a 
potential factor of the HCC development. Moreover, the results of SDS scores, tumor formation rate and survival time 
in both OHCC and DHCC models indicated that while the foundation of spleen-deficiency being existed, the HCC was 
showed to be developed earlier and rapidly. Certainly, the OHCC model had a higher tumor formation rate but a lower 
SDS score and survival time compared to that of DHCC models, which could be explained by the facts that as a 
simulation of primary hepatic carcinoma, HCC model required the tumor tissues should be directly implanted to the 
mice, which made mice get the worse situation and a shorted life expectancy; on the contrary, due to several 
medications and substances being used for model establishment, the DHCC model could simulate the chronic hepatic 
burden such as food, drug and alcohol induced HCC, the symptoms of which were not as severe as that of OHCC, 
therefore the mice could survive a little longer. Besides, even though the SDS model establishment procedure were 
terminated while HCC modeling started, the survival time suggested that a spleen-deficiency factor in advance was 
proven to be harmful for surviving.  
On the whole, these two spleen-deficiency oriented hepatocellular carcinoma mice models were successfully 
according the theory of TCM, which provided the possible approaches to explore the new strategies for hepatic cancer 
by complementary and alternative medicines. However, certain limitation remained in our study. To begin with, we 
have just established two HCC models based on the spleen deficiency in advance, however, the certain mechanism 
underlying the changes of SDS Scale, tumor formation rate and survival rate need to be further confirmed. Furthermore, 
the spleen deficiency is associated with different systems, organs and tissues which should be stimulated by different 
factors, therefore, further SDS model using multi-factors should be explored with the HCC models. Finally, the 
establishment of the models was used for the further studies based on the models, thus several indices should be 
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detected so as to clarify the pathogenesis of HCC, by which the complementary and alternative therapies could be 
found in the futher. 
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